Cargando…

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive loss of lung function with high mortality within the first 5 years from diagnosis. In 2011–2014, two drugs, pirfenidone and nintedanib, have been approved worldwide for prevention of IPF progression. National IPF-registr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pesonen, Ida, Carlson, Lisa, Murgia, Nicola, Kaarteenaho, Riitta, Sköld, Carl Magnus, Myllärniemi, Marjukka, Ferrara, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950183/ https://www.ncbi.nlm.nih.gov/pubmed/29785264 http://dx.doi.org/10.1186/s40248-018-0126-7

Ejemplares similares

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden
por: Kalafatis, Dimitrios, et al.
Publicado: (2019)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland
por: Kaunisto, Jaana, et al.
Publicado: (2023)

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
por: Lehtonen, Siri T., et al.
Publicado: (2016)

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta
Publicado: (2013)

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
por: Gao, Jing, et al.
Publicado: (2021)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa
por: Pesonen, Ida, et al.
Publicado: (2019)

Social inequalities in ageing in the Nordic countries
por: Fritzell, Johan, et al.
Publicado: (2022)

mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2017)

Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD
por: Ishikawa, Nobuhisa, et al.
Publicado: (2010)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
por: Kreus, Mervi, et al.
Publicado: (2022)

Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
por: Kreus, Mervi, et al.
Publicado: (2021)

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry
por: Ferrara, Giovanni, et al.
Publicado: (2016)

National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
por: Salonen, Johanna, et al.
Publicado: (2022)

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2018)

Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD
por: Löfdahl, Magnus, et al.
Publicado: (2011)

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
por: Ferrara, Giovanni, et al.
Publicado: (2018)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis
por: Salonen, Johanna, et al.
Publicado: (2021)

Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways
por: Saraswat, Mayank, et al.
Publicado: (2020)

Are health inequalities really not the smallest in the Nordic welfare states? A comparison of mortality inequality in 37 countries
por: Popham, Frank, et al.
Publicado: (2013)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
por: Partanen, Juulia J., et al.
Publicado: (2022)

Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study
por: Saari, Eeva, et al.
Publicado: (2023)

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment – A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine
por: Koli, Katri, et al.
Publicado: (2016)

End-of-life care of patients with idiopathic pulmonary fibrosis
por: Rajala, Kaisa, et al.
Publicado: (2016)

Anthelmintic resistance. An overview of the situation in the Nordic countries
por: Ihler, Carl Fredrik
Publicado: (2010)

Social Inequalities and Health among Older Immigrant Women in the Nordic Countries: An Integrative Review
por: Debesay, Jonas, et al.
Publicado: (2022)

The first report of autochthonous non-vector-borne transmission of canine leishmaniosis in the Nordic countries
por: Karkamo, Veera, et al.
Publicado: (2014)

Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study
por: Safreed-Harmon, Kelly, et al.
Publicado: (2018)

Several specific high-resolution computed tomography patterns correlate with survival in patients with idiopathic pulmonary fibrosis
por: Mononen, Minna E., et al.
Publicado: (2021)

Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study
por: Paolocci, Giulia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2hnrlorijv6l1e3bj7ppivp3uk